Trials / Conditions / Gastro-esophageal Junction Adenocarcinoma

Gastro-esophageal Junction Adenocarcinoma

4 registered clinical trials studyying Gastro-esophageal Junction Adenocarcinoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally NCT06808971	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2
Active Not Recruiting	Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, NCT06504615	Bristol-Myers Squibb	—
Completed	Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcino NCT03141034	Washington University School of Medicine	Phase 2
Completed	FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarc NCT03283761	Al B. Benson, III, MD	Phase 2